| ［1］ |
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285): 59–65.
|
| ［2］ |
Ahrodia T, Das S, Bakshi S, et al. Structure, functions, and diversity of the healthy human microbiome[J]. Prog Mol Biol Transl Sci, 2022, 191(1): 53–82.
|
| ［3］ |
Foley MH, O’Flaherty S, Allen G, et al. Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization[J]. Proc Natl Acad Sci U S A, 2021, 118(6): e2017709118.
|
| ［4］ |
Collins SL, Stine JG, Bisanz JE, et al. Bile acids and the gut microbiota: metabolic interactions and impacts on disease[J]. Nat Rev Microbiol, 2023, 21(4): 236–247.
|
| ［5］ |
Tarracchini C, Lugli GA, Mancabelli L, et al. Exploring the vitamin biosynthesis landscape of the human gut microbiota[J]. mSystems, 2024, 9(10): e0092924.
|
| ［6］ |
Wu Q, Song D, Zhao Y, et al. Activity of GPCR-targeted drugs influenced by human gut microbiota metabolism[J]. Nat Chem, 2025, 17(6): 808–821.
|
| ［7］ |
Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites[J]. Cell, 2016, 165(6): 1332–1345.
|
| ［8］ |
Lederer AK, Pisarski P, Kousoulas L, et al. Postoperative changes of the microbiome: are surgical complications related to the gut flora? A systematic review[J]. BMC Surg, 2017, 17(1): 125.
|
| ［9］ |
Erawijantari P, Mizutani S, Shiroma H, et al. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles[J]. Gut, 2020, 69(8): 1404–1415.
|
| ［10］ |
Ziegert ZA, Troester A, Frebault J, et al. SparCC co-occurrence networking reveals intracommunity dynamics of the microbiome following colorectal surgery[J]. Microbiol Spectr, 2026, 14(4): e0397325.
|
| ［11］ |
Helliwell JA, Chilton CH, Young C, et al. Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial[J]. Br J Surg, 2025, 112(9): znaf199.
|
| ［12］ |
He Z, Xiong H, Liu L, et al. Influence of postoperative insulin resistance on short-term outcomes of radical gastrectomy for gastric cancer: A microbiome and metabolome-based prospective cohort study[J]. Ann Surg Oncol, 2024, 31(13): 8638–8650.
|
| ［13］ |
Cao W, Zheng C, Xu X, et al. Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy[J]. Front Immunol, 2022, 13: 1076245.
|
| ［14］ |
Sánchez-Alcoholado L, Gutiérrez-Repiso C, Gómez-Pérez AM, et al. Gut microbiota adaptation after weight loss by Roux-en-Y gastric bypass or sleeve gastrectomy bariatric surgeries[J]. Surg Obes Relat Dis, 2019, 15(11): 1888–1895.
|
| ［15］ |
Olsson LM, Borgeraas H, Chakaroun RM, et al. Gut microbiota responses to bariatric surgery are associated with metabolic outcomes and type 2 diabetes remission[J]. Nat Metab, 2026, 8(5): 1212–1228.
|
| ［16］ |
Zhao S, Lin H, Li W, et al. Post sleeve gastrectomy-enriched gut commensal Clostridia promotes secondary bile acid increase and weight loss[J]. Gut Microbes, 2025, 17(1): 2462261.
|
| ［17］ |
Chen Y, Chaudhari SN, Harris DA, et al. A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery[J]. Cell Host Microbe, 2024, 32(8): 1315–1330, e5.
|
| ［18］ |
Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota[J]. Genome Med, 2016, 8(1): 67.
|
| ［19］ |
Fouladi F, Carroll IM, Sharpton TJ, et al. A microbial signature following bariatric surgery is robustly consistent across multiple cohorts[J]. Gut Microbes, 2021, 13(1): 1930872.
|
| ［20］ |
Dao MC, Belda E, Prifti E, et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement[J]. Am J Physiol Endocrinol Metab, 2019, 317(3): E446–E459.
|
| ［21］ |
Palmisano S, Campisciano G, Silvestri M, et al. Changes in gut microbiota composition after bariatric surgery: A new balance to decode[J]. J Gastrointest Surg, 2020, 24(8): 1736–1746.
|
| ［22］ |
Yang KL, Zhai JN, Ye JW, et al. Dysbiosis of gut archaea is associated with obesity and could be recovered after bariatric surgery[J]. Biomed Environ Sci, 2026, 39(4): 437–446.
|
| ［23］ |
Albaugh VL, Banan B, Antoun J, et al. Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery[J]. Gastroenterology, 2019, 156(4): 1041–1051, e4.
|
| ［24］ |
Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy[J]. Nature, 2014, 509(7499): 183–188.
|
| ［25］ |
Hu H, Tian Q, Wang L, et al. Changes of gut microbiota, hormone and glycolipid metabolism by dietary fiber (oat bran) supplementation in patients with laparoscopic sleeve gastrectomy and roux-en-Y gastric bypass: A randomized controlled study[J]. Nutrition, 2026, 147: 113168.
|
| ［26］ |
Homs E, Vives M, Torrell H, et al. Impact of bariatric surgery on the gut microbiota and metabolomic profile of the enterohepatic axis in an experimental model of obesity[J]. Cir Esp (Engl Ed), 2026, 104(4): 800297.
|
| ［27］ |
Komori E, Kato-Kogoe N, Imai Y, et al. Gastrectomy-induced alterations in gut microbiota linked to changes in oral and gastric microbiota[J]. Front Microbiol, 2025, 16: 1599503.
|
| ［28］ |
Yang Y, Zhou HY, Zhou GM, et al. The impact of different gastrointestinal reconstruction techniques on gut microbiota after gastric cancer surgery[J]. Front Microbiol, 2025, 15: 1494049.
|
| ［29］ |
Liang W, Yang Y, Wang H, et al. Gut microbiota shifts in patients with gastric cancer in perioperative period[J]. Medicine (Baltimore), 2019, 98(35): e16626.
|
| ［30］ |
Ilhan ZE, DiBaise JK, Dautel SE, et al. Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery[J]. NPJ Biofilms Microbiomes, 2020, 6(1): 12.
|
| ［31］ |
Pal D, Anandhi A, Keerthi AR, et al. Effect of probiotics on the clinical outcome and inflammatory response in gastric cancer surgery: A double blinded randomized control trial[J]. J Gastrointest Cancer, 2026, 57(1): 93.
|
| ［32］ |
Ye W, Dong B, Li G, et al. The effect of probiotics on surgical outcomes in patients with gastric cancer: A meta-analysis of randomized controlled trials[J]. Front Surg, 2023, 10: 1254597.
|
| ［33］ |
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body[J]. PLoS Biol, 2016, 14(8): e1002533.
|
| ［34］ |
Gaines S, Shao C, Hyman N, et al. Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery[J]. Br J Surg, 2018, 105(2): e131–e141.
|
| ［35］ |
Kim MJ, Park S, Park JW, et al. Gut microbiome associated with low anterior resection syndrome after rectal cancer surgery[J]. Sci Rep, 2023, 13(1): 8578.
|
| ［36］ |
Alverdy JC, Hyman N, Gilbert J. Re-examining causes of surgical site infections following elective surgery in the era of asepsis[J]. Lancet Infect Dis, 2020, 20(3): e38–e43.
|
| ［37］ |
Hajjar R, Gonzalez E, Fragoso G, et al. Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines[J]. Gut, 2023, 72(6): 1143–1154.
|
| ［38］ |
Jacobson RA, Williamson AJ, Wienholts K, et al. Prevention of anastomotic leak via local application of tranexamic acid to target bacterial-mediated plasminogen activation: A practical solution to a complex problem[J]. Ann Surg, 2021, 274(6): e1038–e1046.
|
| ［39］ |
Jin X, Liu Y, Yan W, et al. Gut microbiota from nCAL patients promotes colon anastomotic healing by inducing collagen synthesis in epithelial cells[J]. J Gastroenterol Hepatol, 2022, 37(9): 1756–1767.
|
| ［40］ |
Koskenvuo L, Lunkka P, Varpe P, et al. Morbidity after mechanical bowel preparation and oral antibiotics prior to rectal resection: the MOBILE2 randomized clinical trial[J]. JAMA Surg, 2024, 159(6): 606–614.
|
| ［41］ |
Toh JWT, Phan K, Hitos K, et al. Association of mechanical bowel preparation and oral antibiotics before elective colorectal surgery with surgical site infection: A network meta-analysis[J]. JAMA Netw Open, 2018, 1(6): e183226.
|
| ［42］ |
Žukauskaitė K, Horvath A, Gricius Ž, et al. Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial[J]. Br J Surg, 2024, 111(9): znae213.
|
| ［43］ |
Jalanka J, Salonen A, Salojärvi J, et al. Effects of bowel cleansing on the intestinal microbiota[J]. Gut, 2015, 64(10): 1562–1568.
|
| ［44］ |
Mims TS, Kumari R, Leathem C, et al. Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics[J]. Am J Physiol Gastrointest Liver Physiol, 2023, 325(6): G556–G569.
|
| ［45］ |
Zuo D, Zuo B, Wang L, et al. Impact of a 7-day short peptide diet on gut microbiota and metabolomics in septic mice[J]. Front Nutr, 2025, 12: 1522429.
|
| ［46］ |
Neelis EG, de Koning BAE, Hulst JM, et al. Gut microbiota and its diet-related activity in children with intestinal failure receiving long-term parenteral nutrition[J]. JPEN J Parenter Enteral Nutr, 2022, 46(3): 693–708.
|
| ［47］ |
Weimann A, Braga M, Carli F, et al. ESPEN practical guideline: clinical nutrition in surgery[J]. Clin Nutr, 2021, 40(7): 4745–4761.
|
| ［48］ |
Brăgaru MA, Kraft A, Moldovan CA, et al. Optimizing perioperative nutrition in elective gastrointestinal surgery: An ERAS-focused narrative review[J]. Nutrients, 2026, 18(6): 984.
|
| ［49］ |
Abdul-Hamid S, Fradley W, Phillips BE. Nutritional rehabilitation strategies in abdominal surgery[J]. Curr Opin Clin Nutr Metab Care, 2026, 29(3): 238–245.
|
| ［50］ |
Han Y, Wang Y, Guan M. Preventive effect of probiotics on infections following colorectal cancer surgery: An umbrella meta-analysis[J]. World J Gastrointest Surg, 2024, 16(11): 3546–3558.
|
| ［51］ |
Veziant J, Bonnet M, Occean BV, et al. Probiotics/synbiotics to reduce infectious complications after colorectal surgery: A systematic review and meta-analysis of randomised controlled trials[J]. Nutrients, 2022, 14(15): 3066.
|
| ［52］ |
Gong Y, Ma X, Huang J, et al. Akkermansia muciniphila and osteoporosis: emerging role of gut microbiota in skeletal homeostasis[J]. Front Microbiol, 2025, 16: 1665101.
|
| ［53］ |
Paone P, Petitfils C, Puel A, et al. Akkermansia muciniphila modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice[J]. Gut Microbes, 2026, 18(1): 2612580.
|
| ［54］ |
Chua KJ, Ling H, Hwang IY, et al. An engineered probiotic produces a type Ⅲ interferon IFNL1 and reduces inflammations in in vitro inflammatory bowel disease models[J]. ACS Biomater Sci Eng, 2023, 9(9): 5123–5135.
|
| ［55］ |
Gurbatri CR, Lia I, Vincent R, et al. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies[J]. Sci Transl Med, 2020, 12(530): eaax0876.
|
| ［56］ |
Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10[J]. Science, 2000, 289(5483): 1352–1355.
|
| ［57］ |
Hendrikx T, Duan Y, Wang Y, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice[J]. Gut, 2019, 68(8): 1504–1515.
|
| ［58］ |
Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice[J]. Gut, 2017, 66(4): 569–580.
|
| ［59］ |
Baunwall SMD, Lee MM, Eriksen MK, et al. Faecal microbiota transplantation for recurrent clostridioides difficile infection: An updated systematic review and meta-analysis[J]. EClinicalMedicine, 2020, 29–30: 100642.
|
| ［60］ |
Helliwell JA, Sciberras P, Dosis A, et al. Modulation of the gut microbiota as a novel strategy to prevent anastomotic leak after colorectal surgery: systematic scoping review[J]. Colorectal Dis, 2026, 28(5): e70472.
|
| ［61］ |
Mathewson ND, Jenq R, Mathew AV, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease[J]. Nat Immunol, 2016, 17(5): 505–513.
|
| ［62］ |
Mocanu V, Zhang Z, Deehan EC, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial[J]. Nat Med, 2021, 27(7): 1272–1279.
|
| ［63］ |
Zhang Z, Mocanu V, Deehan EC, et al. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: A secondary analysis of a phase 2 clinical trial[J]. Gut Microbes, 2024, 16(1): 2345134.
|